{
  "id": 15051037,
  "title": "Avicanna Transitions US Listing to OTCQB",
  "url": "https://urgent.news/2026/10/16/avicanna-transitions-us-listing-to-otcqb",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-16T21:30:04.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/avicanna-transitions-us-listing-to-otcqb"
  },
  "original_language": "en",
  "account": null,
  "summary": "TORONTO, Oct. 16, 2026 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or “Company) (TSX: AVCN) (OTCQB: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived cannabinoid-based products announces that in the US, the Company will transition to OTCQB effective October 16, 2026. About Avicanna: Avicanna is an international…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}